HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Man-Fung Yuen Selected Research

Hepatitis B e Antigens

4/2015Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study.
11/2014Hepatitis B surface antigen seroclearance: Relationship to hepatitis B e-antigen seroclearance and hepatitis B e-antigen-negative hepatitis.
5/2014Changes of HBsAg and HBV DNA levels in Chinese chronic hepatitis B patients after 5 years of entecavir treatment.
3/2014HLA-DP and γ-interferon receptor-2 gene variants and their association with viral hepatitis activity in chronic hepatitis B infection.
9/2013Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy.
9/2012A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance.
5/2012Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B.
1/2012A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B.
1/2012High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B.
10/2011Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Man-Fung Yuen Research Topics

Disease

68Chronic Hepatitis B
09/2015 - 02/2002
53Hepatitis B
09/2015 - 11/2002
35Infection
09/2015 - 02/2002
27Fibrosis (Cirrhosis)
07/2015 - 03/2002
19Hepatocellular Carcinoma (Hepatoma)
10/2015 - 03/2002
7Hepatitis
11/2014 - 02/2002
6Neoplasms (Cancer)
12/2015 - 09/2002
5Disease Progression
09/2015 - 08/2004
5Liver Cirrhosis (Hepatic Cirrhosis)
02/2015 - 03/2008
4Viremia
09/2013 - 02/2002
3Liver Neoplasms (Liver Cancer)
10/2015 - 12/2003
3Chronic Hepatitis C
09/2008 - 02/2002
3Liver Diseases (Liver Disease)
12/2007 - 08/2004
2Adenocarcinoma
05/2014 - 05/2003
2Muscular Diseases (Myopathy)
03/2014 - 09/2010
2Gastritis
08/2013 - 05/2003
2Stomach Neoplasms (Stomach Cancer)
10/2012 - 05/2003
2Chronic Hepatitis (Chronic Active Hepatitis)
01/2006 - 01/2006
2Cholangitis
10/2003 - 07/2002
1Neoplasm Metastasis (Metastasis)
12/2015
1Hypertension (High Blood Pressure)
02/2015
1Lymphoma (Lymphomas)
11/2014
1Hematologic Neoplasms (Hematological Malignancy)
11/2014
1Sepsis (Septicemia)
10/2014
1Carcinoma (Carcinomatosis)
05/2014
1Adenoma (Adenomas)
05/2014
1Lactic Acidosis
03/2014
1Hypophosphatemia
03/2014
1Inflammation
08/2013
1HIV Infections (HIV Infection)
06/2013
1Substance-Related Disorders (Drug Abuse)
09/2010
1Peripheral Nervous System Diseases (PNS Diseases)
09/2010
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
08/2007
1Alcoholic Liver Diseases (Alcoholic Liver Disease)
08/2007
1Hemophilia A (Haemophilia)
10/2005
1Abdominal Pain (Pain, Abdominal)
10/2004
1Hepatitis E
06/2004

Drug/Important Bio-Agent (IBA)

46AntigensIBA
04/2015 - 11/2002
43DNA (Deoxyribonucleic Acid)IBA
03/2015 - 07/2002
38Hepatitis B e AntigensIBA
04/2015 - 11/2002
25Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2015 - 06/2004
21Lamivudine (3TC)FDA Link
06/2014 - 07/2002
12entecavirFDA Link
04/2015 - 01/2006
11InterferonsIBA
09/2015 - 04/2003
10Alanine Transaminase (SGPT)IBA
01/2012 - 09/2004
6BilirubinIBA
07/2015 - 03/2002
6telbivudineFDA Link
03/2014 - 09/2004
5Ribavirin (Virazole)FDA LinkGeneric
12/2013 - 04/2003
5alpha-Fetoproteins (AFP)IBA
01/2011 - 09/2002
4Antiviral Agents (Antivirals)IBA
10/2014 - 03/2003
4HLA-DP Antigens (HLA-DP)IBA
03/2014 - 01/2013
4adefovirIBA
01/2013 - 01/2009
3Non-alcoholic Fatty Liver DiseaseIBA
02/2015 - 08/2007
3nasIBA
03/2014 - 01/2007
3tenofovirFDA Link
10/2013 - 01/2011
3Cadherins (E-Cadherin)IBA
08/2013 - 05/2003
3Messenger RNA (mRNA)IBA
08/2013 - 10/2006
3Interferon-alpha (Interferon Alfa)FDA Link
01/2013 - 06/2003
3adefovir dipivoxil (Hepsera)FDA Link
01/2007 - 12/2003
2hepatitis B hyperimmune globulinIBA
11/2014 - 06/2013
2HLA-DPA1 (HLA DPA1)IBA
03/2014 - 01/2014
2Creatine Kinase (Creatine Phosphokinase)IBA
03/2014 - 09/2010
2HLA-DPB1 (HLA DPB1)IBA
01/2014 - 01/2013
2Interleukin-1 (Interleukin 1)IBA
08/2013 - 10/2012
2Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2013 - 10/2012
2VaccinesIBA
10/2012 - 12/2008
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2012 - 03/2002
2ruberythric acid (AlP)IBA
01/2011 - 12/2008
2Biological Markers (Surrogate Marker)IBA
12/2008 - 08/2008
1Coptidis rhizoma extractIBA
12/2015
1huanglianIBA
12/2015
1BerberineIBA
12/2015
1Estrogens (Estrogen)FDA Link
10/2015
1Estradiol (Estrace)FDA LinkGeneric
10/2015
1Reverse Transcriptase InhibitorsIBA
09/2015
1N 30IBA
03/2015
1rituximab (Mabthera)FDA Link
11/2014
12'-fluoro-5-methylarabinosyluracil (Clevudine)IBA
03/2014
1HLA-DQ Antigens (HLA-DQ)IBA
01/2014
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
08/2013
1tenofovir disoproxil (Viread)FDA Link
06/2013
1Surface Antigens (Surface Antigen)IBA
01/2012
1GuanosineIBA
10/2011
1Immunoglobulins (Immunoglobulin)IBA
10/2011
1Estrogen ReceptorsIBA
08/2011
1Estrogen Receptor alphaIBA
08/2011
1Dihydrotachysterol (AT 10)IBA
06/2011
1Carbon MonoxideIBA
01/2011
1Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA
02/2007
1Circular DNAIBA
10/2006
1lysyl- lysyl- leucyl- phenylalanyl- lysyl- lysyl- isoleucyl- leucyl- lysyl- tyrosyl- leucinamideIBA
10/2004

Therapy/Procedure

9Liver Transplantation
06/2015 - 01/2003
3Transplants (Transplant)
11/2014 - 10/2011
2Renal Replacement Therapy (Therapies, Renal Replacement)
10/2014 - 02/2002
2Blood Transfusion (Blood Transfusions)
03/2011 - 09/2010
2Endoscopic Sphincterotomy
10/2003 - 07/2002
1Withholding Treatment
04/2015
1Drug Therapy (Chemotherapy)
11/2014
1Transplantation (Transplant Recipients)
06/2013
1Oral Administration
05/2009